1-1 of 1
Per T. Pedersen, MD
Close
Sort by
Journal Articles

High Dose Simvastatin Has No Beneficial Effect on Markers of Bone Turn-Over in Multiple Myeloma.

Teis E. Sondergaard, MSc, Per T. Pedersen, MD, Thomas L. Andersen, MSc, Thomas Lund, MD, Patrick Garnero, PhD, Jean-Marie Delaisse, PhD, Torben Plesner, MD
Journal: Blood
Blood (2007) 110 (11): 4824.
https://doi.org/10.1182/blood.V110.11.4824.4824
Published: 2007